Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-07 | 2024-09 | -1.85 | N/A | N/A | N/A |
2024-08-01 | 2024-06 | -3.47 | -3.33 | 0.14 | 4.03% |
2024-05-02 | 2024-03 | -3.59 | -3.07 | 0.52 | 14.48% |
2024-05-02 | 2024-03 | -3.59 | N/A | N/A | N/A |
2024-02-22 | 2023-12 | -0.78 | 0.55 | 1.33 | 170.51% |
2024-02-22 | 2023-12 | -0.78 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-12 | Argus Research | Upgrade | Buy | Buy |
2023-08-03 | TD Cowen | Downgrade | Outperform | Market Perform |
2023-08-03 | RBC Capital | Upgrade | Outperform | Outperform |
2023-08-03 | B of A Securities | Upgrade | Neutral | Neutral |
2023-08-03 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-08-02 | Deutsche Bank | Downgrade | Buy | Hold |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-07-30 | AFEYAN NOUBAR BOGHOS | Director | 6.86M | Sale |
2022-12-27 | ANDRES JUAN | Chief Technology Officer | 12.80K | Sale |
2024-02-15 | BANCEL STEPHANE J | Chief Executive Officer | 21.08M | Sale |
2024-05-02 | BERENSON STEPHEN A. | Director | 22.20K | Conversion of Exercise of derivative security |
2023-12-05 | GARAY ARPA | Officer | 3.69K | Sale |
2024-09-02 | HOGE STEPHEN | President | 1.60M | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Baillie Gifford and Company | 45.71M | 5.55B | 12.01% |
2023-06-29 | Vanguard Group Inc | 27.46M | 3.34B | 7.22% |
2023-06-29 | Blackrock Inc. | 24.16M | 2.94B | 6.35% |
2023-06-29 | State Street Corporation | 14.23M | 1.73B | 3.74% |
2023-06-29 | Flagship Pioneering Inc. | 12.89M | 1.57B | 3.39% |
2023-06-29 | Coatue Management LLC | 6.55M | 795.35M | 1.72% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 10.11M | 1.23B | 2.66% |
2023-05-30 | Vanguard International Growth Fund | 9.42M | 1.20B | 2.47% |
2023-06-29 | Vanguard 500 Index Fund | 7.81M | 948.38M | 2.05% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 6.46M | 730.48M | 1.70% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 4.45M | 523.90M | 1.17% |
2023-05-30 | Fidelity 500 Index Fund | 3.70M | 472.16M | 0.97% |
Split | Date |
---|---|
1 : 10 | 2017-08-03 |
-
Wow, it is about time $MRNA gets some love for all the good they have done for this world an saving millions of life. Anything over $218.45 is a win over the bears.
I just hope we close at $230 to just shut them up till we hit the $250. -
We will be testing the $230 this week, heck we might even see the $250!!!!
Don’t sell just yet, and if you hold a few months, you will see the $300 long overdue since the vaccine was approved and moderna sold out. Back in those days Nvax went over the $300s while $MRNA was held back and Bank of America came with the stupid price target of $150 when we were going strong at $186 ready to beat the $200. Now this price of $220-$250 is what the price would have been back in February if it wasn’t for Bank of America. But we all knew they did that to just get in when it went down to the $138 thanks to their own news.
So this price of $220-250 is still low for the kind of earnings Moderna reported last time. -
It is due to beating last ATH of $218.45 back in January 29th and shorts are covering like crazy because they can’t use margin.
-
$250, $250 $250 $250 $250 before ER
Today is the day all previous shorts from back in January 29 have to bring more money to the table or just cover and make the new ATH price even higher.
To the new buyers. Just keep buying and hold till the $300!!What a beautiful day for the bulls that got in like me at $100 ago of earlier. It is time to celebrate. Today is another day to grab a cup of your favorite drink, take a sip, look at the horizon and smile.
Cheers... and have an awesome day my fellow bulls. -
Woooho! The new ATH in regular hrs. Yeah!!!!!
-
Yes yes yes!!! We are back to the ATH of January 29th pre market. 4 months later .
-
Buy buy buy, we are finally going to hit the $250 that we should have hit back on last ER.
-
We will go to $220 first and then will trace back to $210. But because a lot of shorts will be covering, we might just go to $230 to then trace back to $215.
Hold your shares, don’t sell. We will be $300 by the end of the year. -
Short keep shorting please, so we can keep taking your money. We will be $250 before ER
-
Finally it is time for the Bulls to run this all the way to the ATH of $218.45
-
Oh wow, what a party we will continue next week. This week was great.
To all moderna believers, have an awesome weekend and keep smiling -
Buy buy buy, we will hit the $250 before earnings and $300 after earnings. By the way that will be 25% and 50%. With the kind of money moderna is making. The 20% increase can be done in a couple weeks. And think about the ER. The last 3 ER big jumps didn’t happen yet due to crazy news like Bank of America changing price target to $150 when we were at $186 and then the last ER got messed up by the IP patents news. This time we will see the big jump at ER.
So hold your shares and don’t sell. Just buy more when it deeps 5-10% from the high price. -
I used to not like shorts, but thank to them we end up going higher just to squeeze them out of their money. To all the shorts, thanks for the now $82K I got I the last 6 months.
-
Anthony, the PRE market ATH was $218.45 in January 29th
-
I love when I see this kinda days in my account
-
My guess is $205 closing today. If that happens, I will call it a strong $200 price crossing. That means we will see the $215-220 before starts going back to the $200 and that will be the new support. We just need a couple good news to hit the $250 before ER.
-
Moderna deserves to be in the $300 price. With the COVID vaccine alone they made so much money and will continue. But the most important thing is that they saved millions and saved the world from collapsing to a point that would takes decades to recover. I am glad I invested on them and made me $80K richer.
Cheers to all of you that believed and continue believing in this great company. Now grab your cup take a sip, look at the horizon and smile. -
Here is the pipeline that moderna is working on -
-
Let’s go back to the ATH of $218.45 please.
-
NTx Services Launches to Supercharge Next Generation mRNA Research
businesswire.com • -
Moderna (NASDAQ:MRNA) Shares Up 7%
news.google.com • -
Moderna (NASDAQ:MRNA) PT Lowered to $48.00
news.google.com • -
What's Going On With Moderna Shares Tuesday?
news.google.com • -
Where are the Opportunities in (MRNA)
news.google.com • -
Moderna (MRNA) Rises Higher Than Market: Key Facts
news.google.com • -
Moderna (MRNA) Rises Higher Than Market: Key Facts
news.google.com • -
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein
news.google.com • -
Moderna's Recent Drop: 4 Reasons Bulls See Opportunity
marketbeat.com • -
Moderna: Cutting Costs At Just The Worst Time (NASDAQ:MRNA)
news.google.com • -
Moderna: Cutting Costs At Just The Worst Time (NASDAQ:MRNA)
news.google.com • -
Class Action Lawsuit Against Moderna, Inc. (NASDAQ:MRNA)
news.google.com • -
After Moderna's Shocking News, Is the Stock a Buy or a Sell?
news.google.com • -
Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut
news.google.com • -
‘Time to Move to the Sidelines,’ Says Jefferies About Moderna Stock
news.google.com • -
MRNA Stock Falls 12% on Lowered Sales Outlook, R&D Budget Cuts
news.google.com • -
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts
news.google.com • -
Moderna's Move Shows Lack Of Confidence, Shrinks Pipeline (NASDAQ:MRNA)
news.google.com • -
Moderna: Looking For The Bottom (NASDAQ:MRNA)
news.google.com • -
Moderna stock slides on downgrades tied to profitability delay
news.google.com • -
Moderna Stock Falls Again. How the Drug Maker Can Turn Things Around.
news.google.com • -
Moderna: Oddo BHF reduces its target after CMD
news.google.com • -
Moderna (NASDAQ:MRNA) Stock Falls 12% as R&D Budget Is Cut by $1B
news.google.com • -
Moderna (NASDAQ:MRNA) Stock Falls 12% as R&D Budget Is Cut by $1B
news.google.com • -
Moderna (NASDAQ:MRNA) Stock Falls 12% as R&D Budget Is Cut by $1B
news.google.com • -
Big Rate Cut or Small, U.S. Stocks Are Priced for Middling Returns
news.google.com • -
Moderna Stock Hits Lowest Since 2020. What’s Behind the Tumble.
news.google.com • -
Biggest stock movers today: MPW, MRNA, NTGR, and more
news.google.com • -
Moderna Slashes R&D Budget, Stock Plummets Amid Profitability Concerns
news.google.com • -
Moderna Stock Plummets on Cost-Cutting Measures
news.google.com • -
Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know
news.google.com • -
Biggest stock movers today: WBD, MPW, MRNA, SIG, and more (NYSE:OXM)
news.google.com • -
Moderna stock plunges after slashing R&D budget
news.google.com • -
Moderna Stock Drops on Plans To Cut $1.1B in R&D Costs
news.google.com •